Search

everythinglearnresearchcommunity

for

Search:↓

Using finasteride or dutasteride does not increase the risk of male breast cancer.

5 alpha-reductase inhibitors can slightly improve symptoms of enlarged prostate but have a high risk of sexual side effects.

Using 5-alpha reductase inhibitors may increase the risk of mild depression.

5-alpha reductase inhibitors can cause sexual, neurologic, endocrine, and cardiovascular side effects, but these are rare and usually stop after ending treatment.

Dutasteride is cheaper than finasteride for treating benign prostatic hyperplasia.

Prescriptions for 5-alpha reductase inhibitors dropped significantly after the FDA's safety warning, especially for men with benign prostatic hyperplasia.

5-alpha reductase inhibitors can cause sexual side effects like erectile dysfunction and reduced sexual desire, sometimes lasting after stopping the drug.

Using finasteride or dutasteride may cause long-lasting erectile dysfunction.

Urologic diseases and treatments in older men can negatively affect fertility, and doctors should talk to patients about this.

Taking 5-alpha reductase inhibitors does not increase the risk of breast cancer in men.

5-alpha-reductase inhibitors help treat urinary symptoms from an enlarged prostate.

Male pattern hair loss may be linked to the developmental origins of hair follicles.

Finasteride reduces prostate cancer risk but may increase high-grade tumors and has side effects; biopsy methods have similar outcomes; psychosocial factors affect sexual recovery post-surgery.

Male-pattern hair loss is largely influenced by genetics, with key genes identified.

Men over 66 taking medication for prostate enlargement have a higher risk of depression and self-harm, especially in the first 18 months of treatment.

5-alpha reductase inhibitors can cause sexual side effects like erectile dysfunction, but the exact reasons are unclear.

Men taking 5α-reductase inhibitors for enlarged prostate have a higher chance of experiencing reduced sexual desire and erectile dysfunction.

5α-reductase inhibitors increase the risk of sexual dysfunction, especially in men with enlarged prostate.

5-alpha-reductase inhibitors can lower prostate cancer risk but may increase high-grade tumors and cause sexual side effects.

5-alpha-reductase inhibitors may reduce COVID-19 symptoms in bald males.

5-alpha-reductase inhibitors may cause a low incidence of erectile dysfunction that decreases over time.

Finasteride and dutasteride effectively treat hair loss in men and women, but may cause side effects like low libido and depression.

Medications for BPH can have significant side effects, so understanding these risks is important for treatment decisions.

Both dutasteride and finasteride improve urinary symptoms, but dutasteride may be better at reducing the risk of prostate surgery and sudden inability to urinate.

Combination therapy, especially with finasteride, is effective for treating frontal fibrosing alopecia.

Using 5 alpha reductase inhibitors may increase dementia risk in the first two years.

Finasteride and dutasteride are effective for long-term treatment of enlarged prostates but have sexual side effects and a risk of high-grade prostate cancer.

Some treatments can stabilize Frontal Fibrosing Alopecia, but more research is needed to find effective treatments, and hair transplants often fail.

5α-reductase inhibitors may worsen sexual drive and spontaneous erections but don't worsen existing erectile or ejaculatory problems.

The review suggests there's no agreed treatment for Frontal Fibrosing Alopecia, but hydroxychloroquine and 5a-reductase inhibitors are most effective. New treatments like platelet-rich plasma and LED light could help if standard treatments fail.